States across Europe are continuing to ban hexahydrocannabinol (HHC) at pace, as politicians warn that the substance is ‘currently flooding our continent’.
Calls for a blanket European ban on the relatively new, scarcely understood but widely available substance are growing, as are calls to learn the lessons of past prohibition efforts.
Just as it is doing with adult-use cannabis, the Czech Republic is swimming against the tide with HHC, with policy makers pushing for ‘sophisticated legislation’ to regulate HHC and other so-called ‘psychomodulating substances’.
HHC bans
Last month it was reported that France was set to become the 11th European state to attempt to ban or heavily control the substance so far this year.
On 13 June, France officially moved to amend its list of substances classified as narcotics, to include HHC, and its alternatives HHCP and HHCO.
It came just a day after Sweden’s public health agency similarly announced that HHC and HHCP will be classified as narcotics in the country from July 11, 2023.
This came after the substance was added to the list of substances under investigation in October, with another synthetic cannabinoid H4-CBD also being added in April.
Earlier in June, Hungary also notified the EU that it planned to add HHC, HHCO and HHCP to its list of narcotics, making it the 12th EU country to announce such measures.
Encapsulating the general attitudes towards HHC across the union, French MEP Aurélia Beigneux submitted a parliamentary question to the European Commission this month.
Ms Beigneux said that HHC was ‘currently flooding our continent’ due to how easy it was to access the drug, which was ‘benefitting from a legal limbo’ and ‘causing a great deal of concern among doctors’.
“Far from harmless, HHC is not without risks to consumers’ health: it has many adverse effects on the neurological, cardiovascular and digestive systems and can lead to anxiety and depression,” she continued.
In light of this, she questioned whether the EC planned ‘to ban this highly harmful substance from EU markets’ or to ‘run a prevention campaign for Member states’.
“More generally, how does it intend to combat the emergence and marketing of new synthetic drugs?”
‘Beyond Cannabis’ roundtable
In late May, a panel of doctors, researchers, economists and lawyers from both the Czech Republic and the US gathered in Prague’s historic Brožík Town Hall for an open discussion around HHC, and the current approach to regulation.
Organised by Legalizace.cz in collaboration with the esteemed Think Tank for Rational Addiction Policy and attended by prominent individuals including the Czech Republic’s National Coordinator for Drug Policy Jindřich Vobořil, economist Michael Fanta, and Research Director at the Think Tank for Rational Addiction Policy Viktor Mravčík.
Business of Cannabis has previously reported that Mr Vobořil had prepared a draft proposal to regulate HHC and other ‘psychomodulatory’ substances, rather than ban them outright.
He told local media at the time: “HHC is a synthetic substance that is in the grey area for now. I don’t see a reason to necessarily ban it, but it needs to be strictly regulated, just like cannabis.”
In a significant departure from Mr Vobořil’s stance, the country’s National Anti-Drug Headquarters and the Ministry of Defence, supported by the Ministry of Health, put forward proposals to include HHC in the list of addictive substances starting from July 2023, submitting a draft regulation to the EC in May.
The government’s position, and the wider position across Europe, was a key focus during the debate, seeing speakers advocate passionately for a regulated approach.
HHC could have many benefits
While the substance is currently severely under-researched, Martin Kuchař, head of the Laboratory of Forensic Analysis of Biologically Active Substances at VŠCHT, told the conference he believed HHC had an ‘interesting potential’ and ‘deserves further investigation’.
“In animal studies, pain-relieving effects have been found that do not impair the processing of sensory information. At the same time, it seems that it does not have mutagenic or toxic effects on the heart, if the person does not suffer from medical predispositions, and does not damage liver cells.”
Business of Cannabis understands that a number of doctors, all experienced in medical cannabis, spoke of their patients who turned to HHC when they were unable to access medical cannabis and found the results to be similar, with all advocating for the substance to be regulated, not banned.
While the panel agreed that there was nowhere near enough research available to guarantee patient safety, doctor and chairman of the board of the Kopac patient association Pavel Kubů said: “The use of HHC in the case of recreational use is not associated with acute or medium-term side effects that would stem from toxicity.”
This was supported by Christopher Ware, director of the American company KCA Laboratories, which has analysed 20,000 samples with HHC over the past two years.
Discussions also focused on the economic potential of a regulated HHC market, but the overarching consensus of the roundtable was that prohibition was a proven dead end.
Lawyer Vojtěch Sucharda said: “By banning HHC, its spread will not disappear, but it will cease to be controllable; new and worse substances will arrive; they will reach children; the quality and toxicity will deteriorate; and the state will not have the means to solve serious drug problems, which currently HHC certainly does not represent.
“The potential is huge. How we can use it in the Czech Republic depends on what kind of barriers we set for ourselves.”
This article was originally published by Business of Cannabis and is reprinted here with permission.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
__cfduid
1 month
The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
__hssrc
session
This cookie is set by Hubspot. According to their documentation, whenever HubSpot changes the session cookie, this cookie is also set to determine if the visitor has restarted their browser. If this cookie does not exist when HubSpot manages cookies, it is considered a new session.
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-advertisement
1 year
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Cookie
Duration
Description
__hssc
30 minutes
This cookie is set by HubSpot. The purpose of the cookie is to keep track of sessions. This is used to determine if HubSpot should increment the session number and timestamps in the __hstc cookie. It contains the domain, viewCount (increments each pageView in a session), and session start timestamp.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Cookie
Duration
Description
_gat
1 minute
This cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.
ac_enable_tracking
1 month
This cookie is set by the Active Campaign. This cookie is used to keep track of the site usage.
YSC
session
This cookies is set by Youtube and is used to track the views of embedded videos.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cookie
Duration
Description
__hstc
1 year 24 days
This cookie is set by Hubspot and is used for tracking visitors. It contains the domain, utk, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga
2 years
This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid
1 day
This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
hubspotutk
1 year 24 days
This cookie is used by HubSpot to keep track of the visitors to the website. This cookie is passed to Hubspot on form submission and used when deduplicating contacts.
iutk
5 months 27 days
This cookie is used by Issuu analytic system. The cookies is used to gather information regarding visitor activity on Issuu products.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Cookie
Duration
Description
IDE
1 year 24 days
Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
mc
1 year 1 month
This cookie is associated with Quantserve to track anonymously how a user interact with the website.
test_cookie
15 minutes
This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE
5 months 27 days
This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Cookie
Duration
Description
__smSessionId
9 hours
No description
__smVID
1 month
This cookie is set by Sumo. The purpose of the cookie is not yet known.
CONSENT
16 years 8 months 13 days 11 hours
No description
lfuuid
9 years 9 months 13 days 11 hours
Third party (Lead Forensics) cookie which enables us to track visitor behaviour on our site. Tracking is performed anonymously until a user identifies themselves by submitting a form.